Synthesis, spectroscopic characterization, stability assessment and DNA-binding of new 2,6-piperidinedione derivatives

被引:9
作者
Abou-Zeid, L
El-Mowafy, AM
El-Kerdawy, MM
Hamza, H
Abdel-Hamid, ME
机构
[1] Kuwait Univ, Fac Pharm, Dept Appl Therapeut, Safat 13110, Kuwait
[2] Mansoura Univ, Fac Pharm, Dept Med Chem, Mansoura, Egypt
来源
FARMACO | 2001年 / 56卷 / 10期
关键词
2,6-piperidinediones; NIR; HPLC; MS/MS; DNA-binding;
D O I
10.1016/S0014-827X(01)01131-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work reports on structural characterization of new antineoplaston (ANP) representatives, namely 3-(benzoylamino)-2,6-piperidinedione (BPD), 3-(4-methoxybenzoylamino)-2,6-piperidinedione (MPD) and 3-(p-nitrobenzoylamino)-2,6-piperidinedione (NPD). These compounds were prepared by reacting N-(4-substituted benzoyl)-glutamines with N-hydroxysuccinimide to afford the corresponding esters, which were heated to produce the corresponding 2,6-piperidinedione (PD) compounds. Non-destructive analytical procedures such as H-1 NMR and NIR analyses confirmed the postulated chemical structures of these PD compounds. HPLC chromatograms at an ambient temperature or from solutions preheated at 30, 40 or 60 degreesC displayed only a single peak for each compound. Combination of heat with pH modification had virtually no effect on the obtained peaks, thus attesting to the stability and purity of these compounds. MS analysis displayed molecular mass ions indicative of BPD, MPD and NPD at m/z 233.4, 263.2 and 278.3, respectively. The fragmentation patterns using MS/MS analyses conformed to the structural and molecular formulae of the prepared compounds. Furthermore, preliminary biological assessments showed the capacity of these compounds to bind to the DNA. NPD, but not BMP or MPD, had a superior affinity to the DNA than the prototype ANP-A10. (C) 2001 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:763 / 770
页数:8
相关论文
共 17 条
[1]  
Abou-Zeid LA, 2000, ARCH PHARM, V333, P431
[2]   Potential utility of antineoplaston A-10 levels in breast cancer [J].
Badria, F ;
Mabed, M ;
Khafagy, W ;
Abou-Zeid, L .
CANCER LETTERS, 2000, 155 (01) :67-70
[3]   Immune modulatory potentials of antineoplaston A-10 in breast cancer patients [J].
Badria, F ;
Mabed, M ;
El-Awadi, M ;
Abou-Zeid, L ;
Al-Nashar, E ;
Hawas, S .
CANCER LETTERS, 2000, 157 (01) :57-63
[4]   METHYLATION AND IMPRINTING - FROM HOST DEFENSE TO GENE-REGULATION [J].
BARLOW, DP .
SCIENCE, 1993, 260 (5106) :309-310
[5]   Near-infrared spectroscopy in the pharmaceutical industry [J].
Blanco, M ;
Coello, J ;
Iturriaga, H ;
Maspoch, S ;
de la Pezuela, C .
ANALYST, 1998, 123 (08) :135R-150R
[6]   A COLORIMETRIC MICROASSAY FOR THE DETECTION OF AGENTS THAT INTERACT WITH DNA [J].
BURRES, NS ;
FRIGO, A ;
RASMUSSEN, RR ;
MCALPINE, JB .
JOURNAL OF NATURAL PRODUCTS, 1992, 55 (11) :1582-1587
[7]  
BURZYNSKI SR, 1976, PHYSIOL CHEM PHYS M, V8, P275
[8]  
BURZYNSKI SR, 1990, DRUG EXP CLIN RES, V16, P361
[9]  
BURZYNSKI SR, 1986, DRUG EXP CLIN RES, V12, P25
[10]   POTENTIAL OF ANTINEOPLASTONS IN DISEASES OF OLD-AGE [J].
BURZYNSKI, SR .
DRUGS & AGING, 1995, 7 (03) :157-167